EG19690A - Solid oral forms of application containing ifosamide as active substance - Google Patents

Solid oral forms of application containing ifosamide as active substance

Info

Publication number
EG19690A
EG19690A EG46991A EG46991A EG19690A EG 19690 A EG19690 A EG 19690A EG 46991 A EG46991 A EG 46991A EG 46991 A EG46991 A EG 46991A EG 19690 A EG19690 A EG 19690A
Authority
EG
Egypt
Prior art keywords
ifosamide
active substance
solid oral
oral forms
application containing
Prior art date
Application number
EG46991A
Other languages
English (en)
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of EG19690A publication Critical patent/EG19690A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EG46991A 1990-08-03 1991-08-01 Solid oral forms of application containing ifosamide as active substance EG19690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
EG19690A true EG19690A (en) 1995-09-30

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
EG46991A EG19690A (en) 1990-08-03 1991-08-01 Solid oral forms of application containing ifosamide as active substance

Country Status (33)

Country Link
US (1) US5158776A (lv)
EP (1) EP0469440B1 (lv)
JP (2) JP3061898B2 (lv)
KR (1) KR0177170B1 (lv)
CN (1) CN1046851C (lv)
AR (1) AR247484A1 (lv)
AT (1) ATE110261T1 (lv)
AU (2) AU643309B2 (lv)
BG (1) BG60900B1 (lv)
CA (1) CA2048367C (lv)
CZ (1) CZ280475B6 (lv)
DE (2) DE59102620D1 (lv)
DK (1) DK0469440T3 (lv)
EG (1) EG19690A (lv)
ES (1) ES2058999T3 (lv)
FI (1) FI97951C (lv)
HK (1) HK15695A (lv)
HR (1) HRP920575B1 (lv)
HU (1) HU206268B (lv)
IE (1) IE66378B1 (lv)
IL (1) IL99031A (lv)
LT (1) LT3528B (lv)
LV (1) LV10043B (lv)
MC (1) MC2274A1 (lv)
MX (1) MX9100441A (lv)
NO (1) NO178252C (lv)
NZ (1) NZ239222A (lv)
PT (1) PT98532B (lv)
RO (1) RO113611B1 (lv)
SG (1) SG181694G (lv)
SI (1) SI9111342B (lv)
SK (2) SK279740B6 (lv)
ZA (1) ZA916124B (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7966694A (en) * 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN114010629A (zh) * 2014-01-06 2022-02-08 英国神盾Tx股份有限公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
EP0254902B1 (de) * 1986-07-11 1991-08-28 ASTA Pharma Aktiengesellschaft Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
HRP920575A2 (en) 1995-04-30
JP2000229860A (ja) 2000-08-22
LV10043A (lv) 1994-05-10
DE4124481A1 (de) 1992-02-06
SK279740B6 (sk) 1999-03-12
ATE110261T1 (de) 1994-09-15
AU8158991A (en) 1992-02-06
DK0469440T3 (da) 1994-11-14
HU912594D0 (en) 1992-01-28
FI97951B (fi) 1996-12-13
IL99031A0 (en) 1992-07-15
ES2058999T3 (es) 1994-11-01
LV10043B (en) 1995-06-20
NO178252C (no) 1996-02-21
NO913019D0 (no) 1991-08-02
AU4483693A (en) 1993-11-11
PT98532B (pt) 1999-01-29
BG60900B1 (bg) 1996-06-28
IL99031A (en) 1996-09-04
ZA916124B (en) 1992-04-29
EP0469440B1 (de) 1994-08-24
AU649184B2 (en) 1994-05-12
CA2048367C (en) 2000-05-23
NO178252B (no) 1995-11-13
PT98532A (pt) 1992-06-30
FI97951C (fi) 1997-03-25
HUT59316A (en) 1992-05-28
JP3061898B2 (ja) 2000-07-10
SG181694G (en) 1995-05-12
SI9111342B (sl) 1998-10-31
CS240991A3 (en) 1992-03-18
NZ239222A (en) 1993-01-27
DE59102620D1 (de) 1994-09-29
MX9100441A (es) 1992-04-01
IE66378B1 (en) 1995-12-27
NO913019L (no) 1992-02-04
IE912774A1 (en) 1992-02-12
JP3545300B2 (ja) 2004-07-21
JPH04243828A (ja) 1992-08-31
US5158776A (en) 1992-10-27
HRP920575B1 (en) 1999-04-30
MC2274A1 (fr) 1993-06-23
HK15695A (en) 1995-02-10
CN1046851C (zh) 1999-12-01
FI913710A (fi) 1992-02-04
AR247484A1 (es) 1995-01-31
AU643309B2 (en) 1993-11-11
CN1058715A (zh) 1992-02-19
KR920003963A (ko) 1992-03-27
EP0469440A1 (de) 1992-02-05
KR0177170B1 (ko) 1999-03-20
SI9111342A (sl) 1998-04-30
LT3528B (en) 1995-11-27
BG94934A (bg) 1993-12-24
SK279739B6 (sk) 1999-03-12
CZ280475B6 (cs) 1996-01-17
LTIP921A (en) 1995-03-27
FI913710A0 (fi) 1991-08-02
HU206268B (en) 1992-10-28
RO113611B1 (ro) 1998-09-30
CA2048367A1 (en) 1992-02-04

Similar Documents

Publication Publication Date Title
ZA908817B (en) Stable oral composition of zinc
GB8502974D0 (en) Sustained release of active substance
IL113818A0 (en) Pharmaceutical active cns compounds and pharmaceutical compositions containing them
HU9303035D0 (en) N-amino-alkyl-carbonyloxy-alkyl-pyrrol derivatives and insecticidal acaricidal and molluscicidal compositions containing the compounds as active ingredients
PL311918A1 (en) Composition for external application containing an antagonist of p substance
HU9300536D0 (en) Compounds of medical effect
HU9301720D0 (en) Herbicidal preparatives containing substituted 5-amino-pyrazoles as active substance and method for producing said compounds
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
EG19690A (en) Solid oral forms of application containing ifosamide as active substance
ZA881373B (en) Dispenser for the application of active components
HUT49456A (en) Fungicides containing as active substance derivatives of piridil-cycloprophan-carboxamidine
PL288950A1 (en) Apparatu for application of active agent to insects
NZ239813A (en) Fungicidally active compounds, their methods of production and compositions containing them
PL316306A1 (en) Insecticidal composition of active substances
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
GB8817176D0 (en) Combined housing & applicator for cosmetic &c materials
HUT51854A (en) Insecticides containing as active substance derivatives of chrisanthemate
HUT48800A (en) Composition against mollusks containing as active substance 2-/2-chlor-1-metoxi-etoxi/-phenil-methil carbamate
ZA908278B (en) Fungicidal combinations of active compounds
GB8332164D0 (en) Of 4949 physiologically active substance
HU9202971D0 (en) Hetero-polycyclic biocidical compounds and preparatives containing them as active substance
HU906379D0 (en) Producing active substance of medicament
AU1546088A (en) An oral composition containing particles comprising an active substance
HU9601052D0 (en) Insecticidal composition containing combination of active ingredients
GB9400970D0 (en) Manufacture of an oral solid dose form of lactitol